Cargando…

Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis

BACKGROUND: IgA nephropathy (IgAN) is one of the significant contributing factors of end-stage renal disease (ESRD). It is reported that over half of patients with IgAN accompany multiple high-risk factors, which increase the risk of ESRD progression. Studies have shown that immunosuppressive agents...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tongtong, Wang, Yuyang, Mao, Huimin, Yang, Liping, Zhan, Yongli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909110/ https://www.ncbi.nlm.nih.gov/pubmed/33663060 http://dx.doi.org/10.1097/MD.0000000000024541

Ejemplares similares

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020)

IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Hypertension/prehypertension and its determinants in pediatric IgA nephropathy
por: Fu, Qing-Ying, et al.
Publicado: (2020)

Pregnancy-induced complications in IgA nephropathy: A case report
por: Chen, Hui, et al.
Publicado: (2018)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

Clinicopathological analysis of IgA nephropathy combined with other glomerular diseases
por: Jiang, Lei, et al.
Publicado: (2019)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Pneumocystis pneumonia secondary to intensive immunosuppression treatment for anti-GBM disease complicated with IgA nephropathy: A case report and literature review
por: Zhang, Manyu, et al.
Publicado: (2021)

The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)
por: Peng, Wei, et al.
Publicado: (2016)

Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis
por: Liu, Tongtong, et al.
Publicado: (2020)

Differential expression of transfer RNA-derived small RNAs in IgA nephropathy
por: Luo, Zhi-Feng, et al.
Publicado: (2020)

Weight gain promotes the progression of IgA nephropathy in Asians: A protocol for systematic review and meta-analysis
por: Liu, Meixi, et al.
Publicado: (2022)

Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison
por: Ismail, Gener, et al.
Publicado: (2020)

Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report
por: Tanabe, Katsuyuki, et al.
Publicado: (2020)

IgA nephropathy with minimal change disease associated with primary Sjögren’s syndrome: A case report
por: Choi, Jungyoon, et al.
Publicado: (2023)

High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review
por: Chen, Huihui, et al.
Publicado: (2023)

Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Association of Megsin Gene Variants With IgA Nephropathy in Northwest Chinese Population: A STROBE-Compliant Observational Study
por: Wei, Lin-Ting, et al.
Publicado: (2016)

Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis
por: Liu, Ling, et al.
Publicado: (2021)

Coexisting nutcracker phenomenon and superior mesenteric artery syndrome in a patient with IgA nephropathy: A case report
por: Wang, Chenghua, et al.
Publicado: (2021)

Clinical characterization of polycythemia vera associated with IgA nephropathy in a single Chinese center: A case series
por: Wang, Xia, et al.
Publicado: (2022)

Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy: A protocol for Bayesian network meta-analysis
por: Liu, Shilin, et al.
Publicado: (2022)

Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis
por: Lu, WanJun, et al.
Publicado: (2020)

Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report
por: Han, Wei, et al.
Publicado: (2021)

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis
por: Tan, Jiaxing, et al.
Publicado: (2020)

Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
por: Han, Shisheng, et al.
Publicado: (2021)

Coexistence of Fabry disease with IgM nephropathy: A case report
por: Wu, Huizhen, et al.
Publicado: (2019)

The effect and safety of low-dose Tripterygium wilfordii in patients with type 2 diabetic nephropathy: A meta-analysis
por: Chen, Yixuan, et al.
Publicado: (2022)

Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022)

Idiopathic membranous nephropathy in a patient diagnosed with IgG4-related disease: A case report
por: Ma, XiaoYing, et al.
Publicado: (2020)

Relationship between autoimmune thyroid disease and nephropathy: A clinicopathological study
por: Zhao, Liping, et al.
Publicado: (2021)

Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials
por: Zhang, Zheng, et al.
Publicado: (2019)

Efficacy and safety of evocalcet in treatment of secondary hyperparathyroidism in chronic kidney disease on hemodialysis patients: A protocol for a systematic review and meta-analysis
por: Xie, Jing, et al.
Publicado: (2020)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

The safety and efficacy of low-dose mineralocorticoid receptor antagonists in dialysis patients: A meta-analysis
por: Zhu, Yifan, et al.
Publicado: (2021)

Chinese medicinal herbs for idiopathic membranous nephropathy in adults with nephrotic syndrome: A systematic review of effectiveness and safety
por: Liu, Meifang, et al.
Publicado: (2021)

Danhong injection for the treatment of early diabetic nephropathy: A protocol of systematic review and meta-analysis
por: Huang, Caixia, et al.
Publicado: (2020)

Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
por: Wang, Dan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gv7f29mv724bumlkol916e7rne